Brain Pacemaker Market Will Reach USD 3,740.81 Million by 2026
According to the current analysis of Reports and Data, the global Brain Pacemakers market is expected to reach USD 3,740.81 million by the year 2026, in terms of value at a CAGR of 15.9%. Brain pacemaker is a neurostimulator, having an ability to send electrical impulses, through implanted electrodes, to specific targets in the brain for the treatment of neurological disorders. Deep brain stimulation (DBS) is a neurosurgical procedure involving the placement of brain pacemakers to treat neurological disorders. Increasing healthcare expenditure investments in the market, which augment the technological advancements in brain pacemakers are estimated to shape the growth of the brain pacemaker market. These advancements include enhanced microelectrode designs, robot-assisted implantation, multi-target stimulation, integrated implantable pulse generators, individualized directed programming, and magnetic resonance imaging (MRI). Due to the technological advancements in recent times, brain pacemakers have demonstrated lesser adverse effects and greater efficacy and symptomatic relief in patients with movement disorders as compared to conventional methods. Also, the potential benefits of deep brain stimulation therapy, such as better management of postoperative outcomes and long-term efficacy, are projected to facilitate growth of the brain pacemaker market over the forecast period. Furthermore, these advancements aid clinical researchers and physicians in investigational efficacy studies for the usage of Deep brain stimulation (DBS) in off-label clinical applications such as depression. However, high costs associated with brain pacemakers is anticipated to impede the market growth. Conversely, untapped potential of emerging economies such as China, India and Brazil is anticipated to provide attractive growth opportunities to the market players in the forecast period.
Get a sample copy of the Brain Pacemaker Market report, visit @
https://www.reportsanddata.com/download-free-sample/1999
Key findings from the report suggest
- The single
channel product type segment of global brain pacemaker market is expected
to grow at a high CAGR by 2026. The significant share is due to the use
& adoption of the single channel devices across different medical
settings. This segment is observed to grow enormously in the study period
- Different
products are anticipated to be launched in the analysis period in the
brain pacemaker market. Abbot is anticipated to improve on its its St.
Jude medical infinity
- DBS system.
- Along with
groundbreaking technology to help Parkinson's, this system uses a wireless
IOS device (an Apple iPod) to control stimulation. It is a feature allows
patients to receive discreet, personalized treatment in the palm of their
hand.
- The handheld
programmer will enable to control how much or how little stimulation the
patient needs, which is another breakthrough to enhance patient care.
- Clinical
evidence from the INTREPID study reported that patients treated with the
Vercise System sustained a 48% improvement in motor function as measured
by the Unified Parkinson's Disease Rating Scale (UPDRS).
- The three
major manufacturers of brain pacemaker focused on neurology and had
approximately $1billion in combined sales in the most recent reported
quarter. Medtronic's brain therapies group is the leader, with $522 million
in sales in the most recent quarter, though it does not break out DBS
sales specifically. Abbott's neuromodulation unit had $300 million in
global sales, with approximately 10% coming from DBS sales, but it says
DBS has been growing since its launch in the U.S. last year.
- Abbott
Laboratories acquired the DBS business with its acquisition of St. Jude
Medical last year; and Boston Scientific, which currently offers its DBS
system in Europe, hopes to receive U.S. approval by year-end. The combined
company aimed to offer potent health resources and advanced connected
medical devices to gain momentum in the health care industry.
- An estimated
ten million people globally are affected by Parkinson's disease, causing
symptoms such as shaking or tremors, muscle stiffness, and slowness of
movement.
- The major
players in brain pacemaker market are PINS medical, Boston group, Abbott,
and Medtronic, Aleva neurotherapeutics, and others.
To know more about the latest insights
of the report, visit @
https://www.reportsanddata.com/request-latest-insight/1999
Market segmentation:
This
report forecasts revenue growth at a global, regional & country level, and
provides an analysis of the industry trends in each of the sub-segments from
2016 to 2026. For the purpose of this study, Reports and Data have segmented
the brain pacemaker market into product types, application types, sales
channel, end user type and region.
Based on the product: (Revenue, USD Million; 2016-2026):
- Single Channel
- Dual Channel
Based on Applications (Revenue, USD Million; 2016-2026):
- Parkinson's
Disease
- Epilepsy
- Dystonia
- Alzheimer's
- Essential
Tremor
- Obsessive-Compulsive
Disorder
Based on the end-user: (Revenue,
USD Million; 2016-2026)
- Hospitals
- Ambulatory
Surgical Centers & Clinics
- Others
Based on the Sales channel (Revenue, USD Million; 2016-2026)
- Channel sales
- Direct sales
Based on Region (Revenue, USD Million; 2016-2026)
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- France
- UK
- Spain
- Italy
- Rest of the
Europe
- Asia Pacific
- China
- India
- Japan
- Rest of
Asia-Pacific
- Middle East
& Africa
- Latin America
- Brazil
- Rest of Latin
America
Request a customized copy of the
report @
https://www.reportsanddata.com/request-customization-form/1999
Thank you for reading our report. To inquire
about customization or any query about the report, please get in touch with us.
Our team will make sure the report is best suited to your needs.
About Reports and
Data
Reports and Data is
a market research and consulting company that provides syndicated research
reports, customized research reports, and consulting services. Our solutions
purely focus on your purpose to locate, target, and analyze consumer behaviour
shifts across demographics, across industries, and help clients to make smarter
business decisions. We offer market intelligence studies ensuring relevant and
fact-based research across multiple industries, including Healthcare, Touch
Points, Chemicals, Products, and Energy. We consistently update our research
offerings to ensure our clients are aware of the latest trends existent in the
market. Reports and Data has a strong base of experienced analysts from varied
areas of expertise. Our industry experience and ability to develop a concrete
solution to any research problems provides our clients with the ability to
secure an edge over their respective competitors.
Contact:
John W, Head of Business Development
Reports And Data | Web: www.reportsanddata.com
Direct Line: +1-212-710-1370
E-mail: sales@reportsanddata.com
LinkedIn | Twitter | Blogs
Comments
Post a Comment